Go to the list of all blogs
Vitalii Liubimov's Avatar
published in Blogs
Jul 12, 2023

Robot Rally: Unleashing Profit Potential in NVAX and Beyond (+4% in a Week!).

On the American stock market, we are currently witnessing an excellent trend, with new highs being set almost every day. Our robots, including the ones mentioned below, have capitalized on this momentum, earning over 4% in just the past week. These robots can be found at the following links:

These robots are particularly suitable for traders who prefer a balanced strategy. The Day Trader robots focus on stocks with medium and high volatility, allowing traders to adapt their trading algorithms based on market activity.

Here's how these robots operate:

Step 1: The algorithms evaluate the short- and medium-term trends for each stock. Step 2: Using a proprietary set of technical indicators, the robots identify signals to open trades. Step 3: Based on the volatility and direction of the trends, separate algorithms determine the position size for each trade.

Once a trade is initiated, the AI robots set a "Take Profit" order, with the distance determined by the current market volatility. To exit a position, the robots utilize a 3% stop loss of the opening price and a flexible trailing stop, which helps preserve profits in case of a market reversal.

Please note that the robot's trading results are displayed without the use of margin. For comprehensive trading statistics and an equity chart, you can click on the "Show More" button on the robot's page. The "Open Trades" tab allows you to observe how the AI robot selects and executes trades in real-time, while the "Closed Trades" tab provides a record of all past trades conducted by the robot.

Join us as we explore the exciting world of automated trading and uncover the potential of NVAX and other stocks in this exhilarating market surge.

Related Ticker: NVAX

NVAX in upward trend: price may jump up because it broke its lower Bollinger Band on March 27, 2026

NVAX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 34 cases where NVAX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NVAX's RSI Indicator exited the oversold zone, of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where NVAX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NVAX advanced for three days, in of 249 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NVAX as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for NVAX turned negative on March 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

NVAX moved below its 50-day moving average on March 24, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for NVAX crossed bearishly below the 50-day moving average on March 31, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVAX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NVAX entered a downward trend on April 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. NVAX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (32.468) is normal, around the industry mean (26.237). P/E Ratio (3.147) is within average values for comparable stocks, (45.192). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.779). Dividend Yield (0.000) settles around the average of (0.034) among similar stocks. P/S Ratio (1.251) is also within normal values, averaging (317.141).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVAX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Sarepta Therapeutics (NASDAQ:SRPT), Nektar Therapeutics (NASDAQ:NKTR), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Novavax (NASDAQ:NVAX), Inovio Pharmaceuticals (NASDAQ:INO).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.24B. The market cap for tickers in the group ranges from 58 to 110.97B. VRTX holds the highest valuation in this group at 110.97B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 1%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 5%. MLLCF experienced the highest price growth at 79%, while CYCN experienced the biggest fall at -49%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was 58%. For the same stocks of the Industry, the average monthly volume growth was 104% and the average quarterly volume growth was 90%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 83
Price Growth Rating: 58
SMR Rating: 92
Profit Risk Rating: 94
Seasonality Score: -10 (-100 ... +100)
View a ticker or compare two or three
NVAX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NVAX showed earnings on February 26, 2026. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a company which engages in development of novel recombinant vaccines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
700 Quince Orchard Road
Phone
+1 240 268-2000
Employees
1534
Web
https://www.novavax.com
Interact to see
Advertisement
The SPDR S&P 500 ETF Trust (SPY), designed to track the performance of the S&P 500 Index, is a cornerstone of global investment portfolios.
Tickeron, a leader in AI-powered trading solutions, today announced groundbreaking results from its AI Trading Double Agent operating on a 5-minute timeframe for MPWR and SOXS trades.
As financial markets navigate cautious waters today, Tickeron, a pioneer in AI-driven trading solutions, has issued a resounding Buy signal for Asset Entities Inc. (NASDAQ: ASST), highlighting an 85% bullish trend probability.
Tickeron, the leading AI-powered platform for stock analysis and trading, today highlights a bullish outlook for Bitfarms Ltd. (NASDAQ: BITF), with multiple technical indicators signaling strong upward momentum. As the stock closes at $2.77 with a 7.34% daily gain, Tickeron’s advanced algorithms predict high probabilities of further growth, empowering investors with data-driven insights.
Tickeron, the pioneering AI-driven financial technology platform, today unveiled its groundbreaking AI Trend Prediction Engine (TPE), empowering traders with daily buy/sell signals boasting up to 90% odds of success.
#artificial_intelligence
Tickeron, a pioneer in AI-driven financial solutions, today unveiled groundbreaking performance results from its advanced AI Trading Agents, achieving an impressive +61% annualized return using ultra-short 15-minute machine learning intervals.
Tickeron, a pioneer in AI-driven trading solutions, today unveiled its comprehensive forecast, quote, news, and analysis for Opendoor Technologies Inc. (OPEN). Leveraging advanced AI algorithms and Financial Learning Models (FLMs),
Tickeron, a pioneer in AI-powered trading solutions, today announced outstanding results from its AI Trading Agent focused on ProShares Ultra Gold (UGL). Over an 88-day period, the agent delivered an impressive +91% annualized return, generating $16,314 in closed trades profit and loss (P/L).
#artificial_intelligence
ASST’s Stochastic Oscillator has remained in the oversold zone for 10 consecutive days, signaling a potential reversal. Historical data from Tickeron.com indicates that prolonged stays in this zone often precede sharp recoveries. In similar scenarios analyzed over the past five years, stocks lingering in oversold territory for over a week bounced back in 72% of 150 cases, with average gains of 12.4% within the following month.
Tickeron, a pioneer in AI-driven financial tools, today unveiled groundbreaking performance from its AI Robots, delivering annualized returns of up to +54% across high-volatility sectors. As U.S. stock futures climb despite an ongoing government shutdown—with the Dow Jones up 0.2%, S&P 500 gaining 0.3%, and Nasdaq futures rising on AMD’s multi-billion-dollar OpenAI deal—Tickeron’s autonomous trading agents continue to outperform, capturing alpha in real-time market shifts.
Tickeron, a pioneer in AI-powered trading solutions, today announced exceptional performance from its latest AI Trading Agents, showcasing annualized returns up to +64% across popular tickers like XAR, ITA, and SOXL. Leveraging advanced Financial Learning Models (FLMs), these agents are revolutionizing intraday trading with shorter machine learning time frames of 15 minutes and 5 minutes, enabling traders to capitalize on rapid market shifts.
#artificial_intelligence#trading
Tickeron, a pioneer in AI-driven trading solutions, today highlighted the exceptional performance of its advanced AI Trading Bots, delivering annualized returns as high as 82% amid surging global markets. As U.S. stock futures climb— with Dow Jones futures up 0.2%, S&P 500 futures gaining 0.3%, and Nasdaq-100 contracts rising 0.4%—driven by AMD’s multi-billion-dollar deal with OpenAI and Tesla’s pre-event buzz, Tickeron’s bots continue to outperform, adapting swiftly to intraday volatility and government shutdown uncertainties.
As a financial analyst, writer, and AI specialist at Tickeron, I analyze NWBO (Northwest Biotherapeutics, Inc.) through proprietary AI models, revealing strong bullish signals. On September 30, 2025, NWBO broke its lower Bollinger Band, historically preceding rises in 33 of 36 cases (90% probability) within the next month.
Tickeron, a pioneer in AI-driven trading solutions, today unveiled groundbreaking performance results from its advanced AI Trading Agents, showcasing annualized returns as high as +206% in ultra-short 5-minute machine learning cycles.
#artificial_intelligence
Leading AI-Powered Trading Solutions Provider: As a financial analyst, writer, and artificial intelligence specialist, this press release provides a comprehensive forecast, quote, news, and analysis for Micron Technology (MU) stock, leveraging advanced AI insights from Tickeron.com.
#trading#artificial_intelligence
Tickeron, a pioneer in AI-powered trading solutions, today releases its comprehensive forecast, quote, news, and analysis for Alibaba Group Holding Limited (BABA) stock. Leveraging advanced Financial Learning Models (FLMs) and Machine Learning Models (MLMs), Tickeron’s AI tools highlight BABA’s robust performance, including a 54.30% year-to-date gain and a current +5.94% uptrend over three consecutive days.
#artificial_intelligence
Tickeron, a pioneer in AI-powered financial tools, today announced the release of enhanced AI Trading Agents utilizing groundbreaking 5-minute and 15-minute Machine Learning (ML) time frames.
#artificial_intelligence
Tickeron, a pioneer in AI-driven trading solutions, today announced exceptional performance from its AI Trading Agent specialized in NVIDIA Corporation (NVDA) stock. Leveraging advanced 15-minute and weekly data analysis, the agent achieved an impressive annualized return of 375.27%, highlighted by closing 9 out of 9 trades profitably over the past week.
A Roth IRA is widely regarded as one of the most powerful retirement savings tools available. Since contributions are made with after-tax income, all qualified withdrawals — including both contributions and investment gains after age 59½ — are entirely tax-free, provided you follow the account’s guidelines.
#trading